Nearly Two-Thirds Of Prescriptions Initially Filled By Medicare Beneficiaries Were For Brand-Name Drugs, Study Finds
Main Category: Medicare / Medicaid / SCHIPAlso Included In: Pharmacy / Pharmacist; Pharma Industry / Biotech Industry
Article Date: 26 Sep 2008 - 8:00 PDT
| Patient / Public: | ![]() |
2.75 (4 votes) |
| Healthcare Prof: | ![]() |
3 (1 votes) |
| Article Opinions: | 1 posts |
Medicare beneficiaries enrolled in the prescription drug benefit are more likely to ask pharmacists for generic medications when they pay for them and for more expensive brand-name treatments when the program provides coverage, according to a study released on Thursday by Medco Health Solutions, the AP/San Francisco Chronicle reports.
According to the study, brand-name medications accounted for almost two-thirds of all prescriptions initially filled by Medicare beneficiaries. The majority of Medicare beneficiaries switched to generic medications only after they reached the so-called "doughnut hole" coverage gap, in which they must cover the full cost of the prescriptions, the study found. The study also found that brand-name medications accounted for 59% of prescriptions filled by Medicare beneficiaries who received catastrophic coverage, under which the program covers 95% of the prescriptions' cost.
Medco Chief Medical Officer Woody Eisenberg said that, when Medicare beneficiaries reach the coverage gap, they "become acutely aware of the cost difference between brand-name and generic drugs and most make the switch."
Tricia Neuman, a Kaiser Family Foundation vice president and director of the Medicare Policy Project at the foundation, said, "It may be a question of education, that some people simply believe brand-name drugs work better than generics." Research indicates that physicians in most cases do not discuss the potential cost savings of generic medications, Neuman added (Perrone, AP/San Francisco Chronicle, 9/25).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our medicare / medicaid / schip section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/123127.php>
APA
http://www.medicalnewstoday.com/releases/123127.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Always More Than One Explanation
posted by Adi Treasurywala on 26 Sep 2008 at 11:14 amThe study may also show that physicians realize the value of brand name drugs but are conscious of the cost to their patients and switch them when they have to pay the cost themselves as a better alternative to not taking the medication at all.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




